-
Author
Amato, Maria Pia 1 Boz, Cavit 1 Butzkueven, Helmut 1 Buzzard, Katherine 1 Casey, Romain 1 Ciron, Jonathan 1 Clavelou, Pierre 1 Debouverie, Marc 1 Edan, Gilles 1 Gerlach, Oliver 1 Grammond, Pierre 1 Grand'Maison, Francois 1 Havrdova, Eva 1 Horakova, Dana 1 Izquierdo, Guillermo 1 Kalincik, Tomas 1 Lechner-Scott, Jeannette 1 Leray, Emmanuelle 1 Madueño, Sara Eichau 1 Malpas, Charles 1
- Organization
-
Workplace
Aix Marseille Univ APHM Hôpital de la Timone... 1 CHU Clermont Ferrand Department of Neurology 1 CHU de Toulouse Hôpital Pierre Paul Riquet D... 1 CISSS Chaudière Appalache Lévis Canada 1 Central Clinical School Monash University 1 Centre hospitalier universitaire de Rennes H... 1 Department of Medical and Surgical Sciences ... 1 Department of Neurology Box Hill Hospital Mo... 1 Department of Neurology John Hunter Hospital... 1 Department of Neurology The Alfred Hospital ... 1 Department of Neurology Zuyderland Medical C... 1 Department of Neurology and Center of Clinic... 1 Department of Neurosciences Psychology Drugs... 1 Dokuz Eylul University Konak Izmir Turkey 1 EUGENE DEVIC EDMUS Foundation Against Multip... 1 France Centre des Neurosciences de Lyon Obse... 1 From the CORe Department of Medicine Univers... 1 General University Hospital Prague Czech Rep... 1 Hospices Civils de Lyon Service de Neurologi... 1 Hospital Universitario Virgen Macarena Sevil... 1
- Format
- Publication type
- Check Tag
- Category
- Language
- Country
- Journal/source
- Owner
-
Roos, Izanne
Author Roos, Izanne From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne Melbourne MS Centre (I.R., K.B., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes University (E.L.), EHESP, REPERES EA 7449 Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes) Université de Lyon (R.C.), Université Claude Bernard Lyon 1 Hospices Civils de Lyon (R.C.), Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron Observatoire Français de la Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292 EUGENE DEVIC EDMUS Foundation Against Multiple Sclerosis (R.C.), state-approved foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.H.), First Faculty of Medicine, Charles University General University Hospital (D.H., E.H.), Prague, Czech Republic Hospital Universitario Virgen Macarena (G.I., S.E.M.), Sevilla, Spain Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia Multiple Sclerosis Center (F.P.), University of Catania, Italy Centre hospitalier universitaire de Rennes (G.E.), Hôpital Pontchaillou, Service de neurologie, CIC1414 INSERM Nancy University Hospital (M.D.), Department of Neurology Université de Lorraine (M.D.), APEMAC, Nancy, France Aix Marseille Univ (J.P.), APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Dokuz Eylul University (S.O.), Konak/Izmir, Turkey Department of Neurosciences, Psychology, Drugs and Child Health Area (NEUROFARBA) (M.P.A.), Section Neurosciences, University of Florence, Italy CHU Clermont-Ferrand (P.C.), Department of Neurology Université Clermont Auvergne (P.C.), Inserm, Neuro-Dol, Clermont-Ferrand, France CISSS Chaudière-Appalache (P.G.), Lévis, Canada KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey Department of Neurology (K.B., O.S., H.B.), Box Hill Hospital, Monash University The Alfred Hospital (O.S.), Melbourne, Australia CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, Toulouse Cedex 9, France Department of Neurology (O.G.), Zuyderland Medical Center, Sittard-Geleen, the Netherlands Neuro Rive-Sud (F.G.), Quebec, Canada School of Medicine and Public Health (J.L.-S.), University Newcastle Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle Central Clinical School (H.B.), Monash University Department of Neurology (H.B.), The Alfred Hospital, Melbourne, Australia Service de neurologie (S.V.), sclérose en plaques, pathologies de la myéline et neuro-inflammation Hôpital Neurologique Pierre Wertheimer (S.V.), Hospices Civils de Lyon, Lyon/Bron France Centre des Neurosciences de Lyon (S.V.), Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292 and Université Claude Bernard Lyon 1 (S.V.), Faculté de médecine Lyon Est, France
-
Leray, Emmanuelle
Author Leray, Emmanuelle From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne Melbourne MS Centre (I.R., K.B., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes University (E.L.), EHESP, REPERES EA 7449 Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes) Université de Lyon (R.C.), Université Claude Bernard Lyon 1 Hospices Civils de Lyon (R.C.), Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron Observatoire Français de la Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292 EUGENE DEVIC EDMUS Foundation Against Multiple Sclerosis (R.C.), state-approved foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.H.), First Faculty of Medicine, Charles University General University Hospital (D.H., E.H.), Prague, Czech Republic Hospital Universitario Virgen Macarena (G.I., S.E.M.), Sevilla, Spain Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia Multiple Sclerosis Center (F.P.), University of Catania, Italy Centre hospitalier universitaire de Rennes (G.E.), Hôpital Pontchaillou, Service de neurologie, CIC1414 INSERM Nancy University Hospital (M.D.), Department of Neurology Université de Lorraine (M.D.), APEMAC, Nancy, France Aix Marseille Univ (J.P.), APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Dokuz Eylul University (S.O.), Konak/Izmir, Turkey Department of Neurosciences, Psychology, Drugs and Child Health Area (NEUROFARBA) (M.P.A.), Section Neurosciences, University of Florence, Italy CHU Clermont-Ferrand (P.C.), Department of Neurology Université Clermont Auvergne (P.C.), Inserm, Neuro-Dol, Clermont-Ferrand, France CISSS Chaudière-Appalache (P.G.), Lévis, Canada KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey Department of Neurology (K.B., O.S., H.B.), Box Hill Hospital, Monash University The Alfred Hospital (O.S.), Melbourne, Australia CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, Toulouse Cedex 9, France Department of Neurology (O.G.), Zuyderland Medical Center, Sittard-Geleen, the Netherlands Neuro Rive-Sud (F.G.), Quebec, Canada School of Medicine and Public Health (J.L.-S.), University Newcastle Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle Central Clinical School (H.B.), Monash University Department of Neurology (H.B.), The Alfred Hospital, Melbourne, Australia Service de neurologie (S.V.), sclérose en plaques, pathologies de la myéline et neuro-inflammation Hôpital Neurologique Pierre Wertheimer (S.V.), Hospices Civils de Lyon, Lyon/Bron France Centre des Neurosciences de Lyon (S.V.), Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292 and Université Claude Bernard Lyon 1 (S.V.), Faculté de médecine Lyon Est, France
-
Casey, Romain
Author Casey, Romain From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne Melbourne MS Centre (I.R., K.B., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes University (E.L.), EHESP, REPERES EA 7449 Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes) Université de Lyon (R.C.), Université Claude Bernard Lyon 1 Hospices Civils de Lyon (R.C.), Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron Observatoire Français de la Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292 EUGENE DEVIC EDMUS Foundation Against Multiple Sclerosis (R.C.), state-approved foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.H.), First Faculty of Medicine, Charles University General University Hospital (D.H., E.H.), Prague, Czech Republic Hospital Universitario Virgen Macarena (G.I., S.E.M.), Sevilla, Spain Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia Multiple Sclerosis Center (F.P.), University of Catania, Italy Centre hospitalier universitaire de Rennes (G.E.), Hôpital Pontchaillou, Service de neurologie, CIC1414 INSERM Nancy University Hospital (M.D.), Department of Neurology Université de Lorraine (M.D.), APEMAC, Nancy, France Aix Marseille Univ (J.P.), APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Dokuz Eylul University (S.O.), Konak/Izmir, Turkey Department of Neurosciences, Psychology, Drugs and Child Health Area (NEUROFARBA) (M.P.A.), Section Neurosciences, University of Florence, Italy CHU Clermont-Ferrand (P.C.), Department of Neurology Université Clermont Auvergne (P.C.), Inserm, Neuro-Dol, Clermont-Ferrand, France CISSS Chaudière-Appalache (P.G.), Lévis, Canada KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey Department of Neurology (K.B., O.S., H.B.), Box Hill Hospital, Monash University The Alfred Hospital (O.S.), Melbourne, Australia CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, Toulouse Cedex 9, France Department of Neurology (O.G.), Zuyderland Medical Center, Sittard-Geleen, the Netherlands Neuro Rive-Sud (F.G.), Quebec, Canada School of Medicine and Public Health (J.L.-S.), University Newcastle Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle Central Clinical School (H.B.), Monash University Department of Neurology (H.B.), The Alfred Hospital, Melbourne, Australia Service de neurologie (S.V.), sclérose en plaques, pathologies de la myéline et neuro-inflammation Hôpital Neurologique Pierre Wertheimer (S.V.), Hospices Civils de Lyon, Lyon/Bron France Centre des Neurosciences de Lyon (S.V.), Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292 and Université Claude Bernard Lyon 1 (S.V.), Faculté de médecine Lyon Est, France
-
Horakova, Dana
Author Horakova, Dana From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne Melbourne MS Centre (I.R., K.B., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes University (E.L.), EHESP, REPERES EA 7449 Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes) Université de Lyon (R.C.), Université Claude Bernard Lyon 1 Hospices Civils de Lyon (R.C.), Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron Observatoire Français de la Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292 EUGENE DEVIC EDMUS Foundation Against Multiple Sclerosis (R.C.), state-approved foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.H.), First Faculty of Medicine, Charles University General University Hospital (D.H., E.H.), Prague, Czech Republic Hospital Universitario Virgen Macarena (G.I., S.E.M.), Sevilla, Spain Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia Multiple Sclerosis Center (F.P.), University of Catania, Italy Centre hospitalier universitaire de Rennes (G.E.), Hôpital Pontchaillou, Service de neurologie, CIC1414 INSERM Nancy University Hospital (M.D.), Department of Neurology Université de Lorraine (M.D.), APEMAC, Nancy, France Aix Marseille Univ (J.P.), APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Dokuz Eylul University (S.O.), Konak/Izmir, Turkey Department of Neurosciences, Psychology, Drugs and Child Health Area (NEUROFARBA) (M.P.A.), Section Neurosciences, University of Florence, Italy CHU Clermont-Ferrand (P.C.), Department of Neurology Université Clermont Auvergne (P.C.), Inserm, Neuro-Dol, Clermont-Ferrand, France CISSS Chaudière-Appalache (P.G.), Lévis, Canada KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey Department of Neurology (K.B., O.S., H.B.), Box Hill Hospital, Monash University The Alfred Hospital (O.S.), Melbourne, Australia CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, Toulouse Cedex 9, France Department of Neurology (O.G.), Zuyderland Medical Center, Sittard-Geleen, the Netherlands Neuro Rive-Sud (F.G.), Quebec, Canada School of Medicine and Public Health (J.L.-S.), University Newcastle Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle Central Clinical School (H.B.), Monash University Department of Neurology (H.B.), The Alfred Hospital, Melbourne, Australia Service de neurologie (S.V.), sclérose en plaques, pathologies de la myéline et neuro-inflammation Hôpital Neurologique Pierre Wertheimer (S.V.), Hospices Civils de Lyon, Lyon/Bron France Centre des Neurosciences de Lyon (S.V.), Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292 and Université Claude Bernard Lyon 1 (S.V.), Faculté de médecine Lyon Est, France
-
Havrdova, Eva
Author Havrdova, Eva From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne Melbourne MS Centre (I.R., K.B., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes University (E.L.), EHESP, REPERES EA 7449 Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes) Université de Lyon (R.C.), Université Claude Bernard Lyon 1 Hospices Civils de Lyon (R.C.), Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron Observatoire Français de la Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292 EUGENE DEVIC EDMUS Foundation Against Multiple Sclerosis (R.C.), state-approved foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.H.), First Faculty of Medicine, Charles University General University Hospital (D.H., E.H.), Prague, Czech Republic Hospital Universitario Virgen Macarena (G.I., S.E.M.), Sevilla, Spain Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia Multiple Sclerosis Center (F.P.), University of Catania, Italy Centre hospitalier universitaire de Rennes (G.E.), Hôpital Pontchaillou, Service de neurologie, CIC1414 INSERM Nancy University Hospital (M.D.), Department of Neurology Université de Lorraine (M.D.), APEMAC, Nancy, France Aix Marseille Univ (J.P.), APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Dokuz Eylul University (S.O.), Konak/Izmir, Turkey Department of Neurosciences, Psychology, Drugs and Child Health Area (NEUROFARBA) (M.P.A.), Section Neurosciences, University of Florence, Italy CHU Clermont-Ferrand (P.C.), Department of Neurology Université Clermont Auvergne (P.C.), Inserm, Neuro-Dol, Clermont-Ferrand, France CISSS Chaudière-Appalache (P.G.), Lévis, Canada KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey Department of Neurology (K.B., O.S., H.B.), Box Hill Hospital, Monash University The Alfred Hospital (O.S.), Melbourne, Australia CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, Toulouse Cedex 9, France Department of Neurology (O.G.), Zuyderland Medical Center, Sittard-Geleen, the Netherlands Neuro Rive-Sud (F.G.), Quebec, Canada School of Medicine and Public Health (J.L.-S.), University Newcastle Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle Central Clinical School (H.B.), Monash University Department of Neurology (H.B.), The Alfred Hospital, Melbourne, Australia Service de neurologie (S.V.), sclérose en plaques, pathologies de la myéline et neuro-inflammation Hôpital Neurologique Pierre Wertheimer (S.V.), Hospices Civils de Lyon, Lyon/Bron France Centre des Neurosciences de Lyon (S.V.), Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292 and Université Claude Bernard Lyon 1 (S.V.), Faculté de médecine Lyon Est, France
-
Izquierdo, Guillermo
Author Izquierdo, Guillermo From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne Melbourne MS Centre (I.R., K.B., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes University (E.L.), EHESP, REPERES EA 7449 Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes) Université de Lyon (R.C.), Université Claude Bernard Lyon 1 Hospices Civils de Lyon (R.C.), Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron Observatoire Français de la Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292 EUGENE DEVIC EDMUS Foundation Against Multiple Sclerosis (R.C.), state-approved foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.H.), First Faculty of Medicine, Charles University General University Hospital (D.H., E.H.), Prague, Czech Republic Hospital Universitario Virgen Macarena (G.I., S.E.M.), Sevilla, Spain Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia Multiple Sclerosis Center (F.P.), University of Catania, Italy Centre hospitalier universitaire de Rennes (G.E.), Hôpital Pontchaillou, Service de neurologie, CIC1414 INSERM Nancy University Hospital (M.D.), Department of Neurology Université de Lorraine (M.D.), APEMAC, Nancy, France Aix Marseille Univ (J.P.), APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Dokuz Eylul University (S.O.), Konak/Izmir, Turkey Department of Neurosciences, Psychology, Drugs and Child Health Area (NEUROFARBA) (M.P.A.), Section Neurosciences, University of Florence, Italy CHU Clermont-Ferrand (P.C.), Department of Neurology Université Clermont Auvergne (P.C.), Inserm, Neuro-Dol, Clermont-Ferrand, France CISSS Chaudière-Appalache (P.G.), Lévis, Canada KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey Department of Neurology (K.B., O.S., H.B.), Box Hill Hospital, Monash University The Alfred Hospital (O.S.), Melbourne, Australia CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, Toulouse Cedex 9, France Department of Neurology (O.G.), Zuyderland Medical Center, Sittard-Geleen, the Netherlands Neuro Rive-Sud (F.G.), Quebec, Canada School of Medicine and Public Health (J.L.-S.), University Newcastle Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle Central Clinical School (H.B.), Monash University Department of Neurology (H.B.), The Alfred Hospital, Melbourne, Australia Service de neurologie (S.V.), sclérose en plaques, pathologies de la myéline et neuro-inflammation Hôpital Neurologique Pierre Wertheimer (S.V.), Hospices Civils de Lyon, Lyon/Bron France Centre des Neurosciences de Lyon (S.V.), Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292 and Université Claude Bernard Lyon 1 (S.V.), Faculté de médecine Lyon Est, France
-
Madueño, Sara Eichau
Author Madueño, Sara Eichau From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne Melbourne MS Centre (I.R., K.B., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes University (E.L.), EHESP, REPERES EA 7449 Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes) Université de Lyon (R.C.), Université Claude Bernard Lyon 1 Hospices Civils de Lyon (R.C.), Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron Observatoire Français de la Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292 EUGENE DEVIC EDMUS Foundation Against Multiple Sclerosis (R.C.), state-approved foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.H.), First Faculty of Medicine, Charles University General University Hospital (D.H., E.H.), Prague, Czech Republic Hospital Universitario Virgen Macarena (G.I., S.E.M.), Sevilla, Spain Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia Multiple Sclerosis Center (F.P.), University of Catania, Italy Centre hospitalier universitaire de Rennes (G.E.), Hôpital Pontchaillou, Service de neurologie, CIC1414 INSERM Nancy University Hospital (M.D.), Department of Neurology Université de Lorraine (M.D.), APEMAC, Nancy, France Aix Marseille Univ (J.P.), APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Dokuz Eylul University (S.O.), Konak/Izmir, Turkey Department of Neurosciences, Psychology, Drugs and Child Health Area (NEUROFARBA) (M.P.A.), Section Neurosciences, University of Florence, Italy CHU Clermont-Ferrand (P.C.), Department of Neurology Université Clermont Auvergne (P.C.), Inserm, Neuro-Dol, Clermont-Ferrand, France CISSS Chaudière-Appalache (P.G.), Lévis, Canada KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey Department of Neurology (K.B., O.S., H.B.), Box Hill Hospital, Monash University The Alfred Hospital (O.S.), Melbourne, Australia CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, Toulouse Cedex 9, France Department of Neurology (O.G.), Zuyderland Medical Center, Sittard-Geleen, the Netherlands Neuro Rive-Sud (F.G.), Quebec, Canada School of Medicine and Public Health (J.L.-S.), University Newcastle Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle Central Clinical School (H.B.), Monash University Department of Neurology (H.B.), The Alfred Hospital, Melbourne, Australia Service de neurologie (S.V.), sclérose en plaques, pathologies de la myéline et neuro-inflammation Hôpital Neurologique Pierre Wertheimer (S.V.), Hospices Civils de Lyon, Lyon/Bron France Centre des Neurosciences de Lyon (S.V.), Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292 and Université Claude Bernard Lyon 1 (S.V.), Faculté de médecine Lyon Est, France
-
Patti, Francesco
Author Patti, Francesco From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne Melbourne MS Centre (I.R., K.B., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes University (E.L.), EHESP, REPERES EA 7449 Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes) Université de Lyon (R.C.), Université Claude Bernard Lyon 1 Hospices Civils de Lyon (R.C.), Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron Observatoire Français de la Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292 EUGENE DEVIC EDMUS Foundation Against Multiple Sclerosis (R.C.), state-approved foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.H.), First Faculty of Medicine, Charles University General University Hospital (D.H., E.H.), Prague, Czech Republic Hospital Universitario Virgen Macarena (G.I., S.E.M.), Sevilla, Spain Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia Multiple Sclerosis Center (F.P.), University of Catania, Italy Centre hospitalier universitaire de Rennes (G.E.), Hôpital Pontchaillou, Service de neurologie, CIC1414 INSERM Nancy University Hospital (M.D.), Department of Neurology Université de Lorraine (M.D.), APEMAC, Nancy, France Aix Marseille Univ (J.P.), APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Dokuz Eylul University (S.O.), Konak/Izmir, Turkey Department of Neurosciences, Psychology, Drugs and Child Health Area (NEUROFARBA) (M.P.A.), Section Neurosciences, University of Florence, Italy CHU Clermont-Ferrand (P.C.), Department of Neurology Université Clermont Auvergne (P.C.), Inserm, Neuro-Dol, Clermont-Ferrand, France CISSS Chaudière-Appalache (P.G.), Lévis, Canada KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey Department of Neurology (K.B., O.S., H.B.), Box Hill Hospital, Monash University The Alfred Hospital (O.S.), Melbourne, Australia CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, Toulouse Cedex 9, France Department of Neurology (O.G.), Zuyderland Medical Center, Sittard-Geleen, the Netherlands Neuro Rive-Sud (F.G.), Quebec, Canada School of Medicine and Public Health (J.L.-S.), University Newcastle Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle Central Clinical School (H.B.), Monash University Department of Neurology (H.B.), The Alfred Hospital, Melbourne, Australia Service de neurologie (S.V.), sclérose en plaques, pathologies de la myéline et neuro-inflammation Hôpital Neurologique Pierre Wertheimer (S.V.), Hospices Civils de Lyon, Lyon/Bron France Centre des Neurosciences de Lyon (S.V.), Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292 and Université Claude Bernard Lyon 1 (S.V.), Faculté de médecine Lyon Est, France
-
Edan, Gilles
Author Edan, Gilles From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne Melbourne MS Centre (I.R., K.B., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes University (E.L.), EHESP, REPERES EA 7449 Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes) Université de Lyon (R.C.), Université Claude Bernard Lyon 1 Hospices Civils de Lyon (R.C.), Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron Observatoire Français de la Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292 EUGENE DEVIC EDMUS Foundation Against Multiple Sclerosis (R.C.), state-approved foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.H.), First Faculty of Medicine, Charles University General University Hospital (D.H., E.H.), Prague, Czech Republic Hospital Universitario Virgen Macarena (G.I., S.E.M.), Sevilla, Spain Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia Multiple Sclerosis Center (F.P.), University of Catania, Italy Centre hospitalier universitaire de Rennes (G.E.), Hôpital Pontchaillou, Service de neurologie, CIC1414 INSERM Nancy University Hospital (M.D.), Department of Neurology Université de Lorraine (M.D.), APEMAC, Nancy, France Aix Marseille Univ (J.P.), APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Dokuz Eylul University (S.O.), Konak/Izmir, Turkey Department of Neurosciences, Psychology, Drugs and Child Health Area (NEUROFARBA) (M.P.A.), Section Neurosciences, University of Florence, Italy CHU Clermont-Ferrand (P.C.), Department of Neurology Université Clermont Auvergne (P.C.), Inserm, Neuro-Dol, Clermont-Ferrand, France CISSS Chaudière-Appalache (P.G.), Lévis, Canada KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey Department of Neurology (K.B., O.S., H.B.), Box Hill Hospital, Monash University The Alfred Hospital (O.S.), Melbourne, Australia CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, Toulouse Cedex 9, France Department of Neurology (O.G.), Zuyderland Medical Center, Sittard-Geleen, the Netherlands Neuro Rive-Sud (F.G.), Quebec, Canada School of Medicine and Public Health (J.L.-S.), University Newcastle Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle Central Clinical School (H.B.), Monash University Department of Neurology (H.B.), The Alfred Hospital, Melbourne, Australia Service de neurologie (S.V.), sclérose en plaques, pathologies de la myéline et neuro-inflammation Hôpital Neurologique Pierre Wertheimer (S.V.), Hospices Civils de Lyon, Lyon/Bron France Centre des Neurosciences de Lyon (S.V.), Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292 and Université Claude Bernard Lyon 1 (S.V.), Faculté de médecine Lyon Est, France
-
Debouverie, Marc
Author Debouverie, Marc From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne Melbourne MS Centre (I.R., K.B., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes University (E.L.), EHESP, REPERES EA 7449 Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes) Université de Lyon (R.C.), Université Claude Bernard Lyon 1 Hospices Civils de Lyon (R.C.), Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron Observatoire Français de la Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292 EUGENE DEVIC EDMUS Foundation Against Multiple Sclerosis (R.C.), state-approved foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.H.), First Faculty of Medicine, Charles University General University Hospital (D.H., E.H.), Prague, Czech Republic Hospital Universitario Virgen Macarena (G.I., S.E.M.), Sevilla, Spain Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia Multiple Sclerosis Center (F.P.), University of Catania, Italy Centre hospitalier universitaire de Rennes (G.E.), Hôpital Pontchaillou, Service de neurologie, CIC1414 INSERM Nancy University Hospital (M.D.), Department of Neurology Université de Lorraine (M.D.), APEMAC, Nancy, France Aix Marseille Univ (J.P.), APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Dokuz Eylul University (S.O.), Konak/Izmir, Turkey Department of Neurosciences, Psychology, Drugs and Child Health Area (NEUROFARBA) (M.P.A.), Section Neurosciences, University of Florence, Italy CHU Clermont-Ferrand (P.C.), Department of Neurology Université Clermont Auvergne (P.C.), Inserm, Neuro-Dol, Clermont-Ferrand, France CISSS Chaudière-Appalache (P.G.), Lévis, Canada KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey Department of Neurology (K.B., O.S., H.B.), Box Hill Hospital, Monash University The Alfred Hospital (O.S.), Melbourne, Australia CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, Toulouse Cedex 9, France Department of Neurology (O.G.), Zuyderland Medical Center, Sittard-Geleen, the Netherlands Neuro Rive-Sud (F.G.), Quebec, Canada School of Medicine and Public Health (J.L.-S.), University Newcastle Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle Central Clinical School (H.B.), Monash University Department of Neurology (H.B.), The Alfred Hospital, Melbourne, Australia Service de neurologie (S.V.), sclérose en plaques, pathologies de la myéline et neuro-inflammation Hôpital Neurologique Pierre Wertheimer (S.V.), Hospices Civils de Lyon, Lyon/Bron France Centre des Neurosciences de Lyon (S.V.), Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292 and Université Claude Bernard Lyon 1 (S.V.), Faculté de médecine Lyon Est, France
OBJECTIVE: To compare the clinical effectiveness of high- and low-efficacy treatments in patients with recently active and inactive secondary progressive multiple sclerosis (SPMS) after accounting for therapeutic lag. METHODS: Patients treated with high-efficacy (natalizumab, alemtuzumab, mitoxantrone, ocrelizumab, rituximab, cladribine, fingolimod) or low-efficacy (interferon beta, glatiramer acetate, teriflunomide) therapies after SPMS onset were selected from MSBase and Observatoire Français de la Sclérose en Plaques (OFSEP), 2 large observational cohorts. Therapeutic lag was estimated for each patient from their demographic and clinical characteristics. Propensity score was used to match patients treated with high- and low-efficacy therapies. Outcomes after the period of therapeutic lag was disregarded were compared in paired, pairwise-censored analyses. RESULTS: One thousand patients were included in the primary analysis. Patients with active SPMS treated with high-efficacy therapy experienced less frequent relapses than those on low-efficacy therapy (hazard ratio [HR] 0.7, p = 0.006). In patients with inactive SPMS, there was no evidence for a difference in relapse frequency between groups (HR 0.8, p = 0.39). No evidence for a difference in the risk of disability progression was observed. CONCLUSION: In treated patients with SPMS, high-efficacy therapy is superior to low-efficacy therapy in reducing relapses in patients with active but not those with inactive SPMS. However, more potent therapies do not offer an advantage in reducing disability progression in this patient group. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that high-efficacy therapy is superior to low-efficacy therapy in reducing relapses in patients with active SPMS, although we did not find a difference in disability progression between patients treated with high- and low-efficacy therapy.
- MeSH
- Multiple Sclerosis, Chronic Progressive * drug therapy MeSH
- Glatiramer Acetate therapeutic use MeSH
- Humans MeSH
- Natalizumab MeSH
- Multiple Sclerosis, Relapsing-Remitting * MeSH
- Multiple Sclerosis * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Comment MeSH
- Research Support, Non-U.S. Gov't MeSH
Share
Document title
The link will be redirected to the address of the production version after the testing phase.